Welcome to ESTRO 36 in Vienna

ESTRO 36

Reed Messe Congress Center — Vienna, Austria
May 5 – May 9, 2017

ViewRay Booth 400

 

ViewRay Satellite Symposium:

MRI-Guided RT with MRIdian®: Perspectives from Installation to Clinical Use

Sunday, May 7 at 1:15pm  Room: Lehar 1-3
Join ViewRay for a lunchtime symposium and hear first-hand clinical experience from institutions treating with MRIdian®, the worlds only MRI-guided radiation therapy system.

 
In-Booth Presentation Schedule:

Saturday, May 6, 2017

10:15 – 10:30 am Michael Bassetti, MD PhD 
University of Wisconsin
1:30 – 1:45 pm Francesco Cellini, MD 
Gemelli ART

Sunday, May 7, 2017

10:15 – 10:30 am Michael Bassetti, MD PhD
University of Wisconsin
4:15 – 4:30 pm Davide Cusumano, PhD
Gemelli ART

Monday, May 8, 2017

10:15 – 10:30 am Nicola Dinapoli, MD
Gemelli ART
1:15 – 2:00 pm Guest Speaker: Bibian Mentel 
Gold Medal Paralympian and MRIdian Patient
4:15 – 4:30 pm Frank Lagerwaard, MD PhD
VU University Medical Center, Amsterdam


ViewRay Presentations of Interest:

Saturday, May 6, 2017

16:30 – 16:40
Room: Straus 1
Novelties in image guidance (046)
OC-0161: Patient tolerance of stereotactic MR-guided adaptive radiation therapy: an assessment using PRO’s
R. Bakker, M. Jeulink, S. Tetar, S. Senan, B. Slotman, F. Lagerwaard, A. Bruynzeel, VU University Medical Center, Radiotherapy, Amsterdam, The Netherlands

Sunday, May 7, 2017

8:45-9:10
Room: Lehar 1-3
Ultra fast online therapy adaptation (replanning, dose accumulation QA) (086)
SP-0212: Automatic image segmentation and structure evaluation for on-line adaptive RT
S. Mutic, Washington University School of Medicine, Department of Radiation Oncology, St. Louis, USA
9:35-9:45
Room: Lehar 5
Dose measurement and dose calculations (923)
OC-0231: The suitability of radiochromic film in 0.35T magnetic field CO-60 compared with conventional 6MV
D. Barten, L. van Battum, D. Hoffmans, S. Heukelom, VUMC, Radiotherapie, Amsterdam, The Netherlands
11:20 – 11:30
Room: Lehar 1-3
Best of online MRI-guided radiotherapy (075)
OC-0262: Implementation of patient specific QA for daily adaptive MR-guided radiation therapy
M. Palacios, T. Apicella, D. Hoffmans, T. Rosario, M. Admiraal, I. Kawrakow*, J. Cuijpers, VU Medical Center, Radiation Oncology Department, Amsterdam, The Netherlands.
*ViewRay- Inc., Research & Development, Mountain View, USA.
Poster Session Upper and lower GI
PV-0322: Rapid Early Response of Gastroesophageal Junction Tumors During Real-time MRI-Guided Radiotherapy
H. Musunuru, S. Rosenberg, J. Bayouth, K. Mitteur, M. Ritter, B. Paliwal, M. Witek, A. Baschnagel, N. Uboha, S. Lubner, N. Loconte, P. Harari, M. Bassetti, University of Wisconsin Hospital and Clinics, Medical Oncology, Madison, USA

Monday, May 8, 2017

9:39 – 9:57
Room: Schubert
MR guided radiotherapy: the new standard of care in 10 years time (114)
SP-0396: Can we perform RCTs evaluating MR guided radiotherapy?
V. Valentini, Università Cattolica del Sacro Cuore – Policlinico A. Gemelli, Gemelli ART, Rome, Italy.
10:40 – 10:50
Room: Auditorium
Upper and Lower GI (121)
OC-0425: Clinical experience with stereotactic MR-guided adaptive radiation therapy for pancreatic tumors
A. Bruynzeel, F. Lagerwaard, O. Bohoudi, S. Tetar, N. Haasbeek, S. Oei, B. Slotman, M. Meijerink, S. Senan, M. Palacios, VU University Medical Center, Radiotherapy, Amsterdam, The Netherlands
15:45 – 16:15
Room: Straus 1
Focus on prostate cancer: what is the best of radiotherapy we need to treat our patients with (141)
SP-0494: Using a MRI-guided radiation therapy system for prostate cancer patients
O. Bohoudi, A. Bruynzeel, S. Senan, B. Slotman, M. Palacios, F. Lagerwaard, VUMC, Radiotherapy, Amsterdam, The Netherlands.
15:55 – 16:05
Room: Lehar 1-3
Inter-fraction motion management (950)
OC-0490: A robust and fast planning approach for adaptive MR-guided treatment of pancreatic cancer
O. Bohoudi, A. Bruynzeel, B. Slotman, S. Senan, F. Lagerwaard, M. Palacios, VUMC, Radiotherapy, Amsterdam, The Netherlands.

Tuesday, May 9, 2017

11:20 – 11:40
Room: Straus 2-3
Applications and challenges in dosimeters for MR-Linacs (173)
SP-0593: Clinical commissioning of MR guided treatment systems
O. Green, Washington University School of Medicine, Department of Radiation Oncology, St. Louis, USA